Launch of QCnow™ Peer Review Program QCnow™ Enables Vidan Diagnostics Customers to Access On-demand Interlaboratory Quality Control Reports. SAN ANTONIO, Texas, June 8, 2020 - Vidan Diagnostics, LLC today announced the launch of its QCnow™ Peer Review Program. QCnow™ is a portal to quality control information, providing laboratory personnel with an easy and rapid way [...]
Reagent Application for Vidan Diagnostics’ β-Hydroxybutyrate 21FS Assay is now available for Abbott Alnity™ Clinical Chemistry System. SAN ANTONIO, Texas, May 18, 2020 - Vidan Diagnostics, LLC today announced that its β-Hydroxybutyrate 21FS Next Generation Reagent can be easily programmed to perform testing on the Abbott Alinity™ clinical chemistry system. Beta-Hydroxybutyrate (BHB) is an important [...]
Vidan Diagnostics Launches its β-Hydroxybutyrate 21FS in Pre-filled Reagent Kits for the Abbott ARCHITECT™ Clinical Chemistry Systems SAN ANTONIO, Texas, December 18, 2019 - Vidan Diagnostics, LLC today announced the availability of its pre-filled reagent kits that allows Abbott ARCHITECT™ customers access to it's Beta-Hydroxybutyrate (BOHB) assay, an important marker used in conjunction with clinical [...]
Availability of Beta-Hydroxybutyrate Reagent on Beckman Coulter AU® Systems Vidan’s pre-filled reagent kits makes it easy to load its β-Hydroxybutyrate 21FS Reagent on AU® clinical chemistry systems SAN ANTONIO, TX – November 01, 2019 – Vidan Diagnostics, LLC today announced the launch of its prefilled reagent kits for the Beckman Coulter AU® clinical chemistry [...]
Vidan Diagnostics Announces Distribution Agreement with Diasys Diagnostics Systems, GmbH. SAN ANTONIO, TX – January 02, 2019– Today, Vidan Diagnostics, LLC, announces that it has entered into an exclusive distribution agreement with German diagnostic reagent manufacturer, Diasys Diagnostics Systems, GmbH, to market in the U.S. Diasys Diagnostics’, FDA cleared liquid-stable, ready-to-use reagent kit for the [...]
SAN ANTONIO, TX – September 25, 2018 Vidan Diagnostics, LLC, was pleased to recently attend the National Association of Freestanding Emergency Centers (NAFEC) Annual Conference to promote the Lucidplus™ B-Ketone plus Glucose Monitoring System September 10-12, 2018 in Irving (Dallas), TX. Vidan Diagnostics representative Gilbert Mejia, CEO, participated in the exhibition to attendees [...]
Vidan Diagnostics Announces the Availability of Glucose Test for Lucidplus™ SAN ANTONIO, TX – September 6, 2018 - Vidan Diagnostics, LLC, is pleased to announce the availability of its glucose test for the Lucidplus™ B-Ketone plus Glucose Monitoring System. Originally launching its first product in the U.S. market with a focus on ketone testing, Vidan [...]
Vidan Diagnostics Announces Distribution Agreement with Medline Industries, Inc. SAN ANTONIO, TX – August 24, 2018– Today, Vidan Diagnostics, LLC, announces that it has signed a distribution agreement with Medline Industries, Inc., the nation’s largest privately-held manufacturer and distributor of medical supplies providing products, education and services across the continuum of care. The agreement follows [...]
Vidan Diagnostics Appoints New Member To Its Executive Team Albert Blanco appointed as Chief Operating Officer SAN ANTONIO, Texas, April 16, 2018 -Vidan Diagnostics, LLC today announced the appointment of Albert Blanco as Chief Operating Officer (COO). Prior to this, Mr. Blanco served as Vice President of Business Development, Vice President of Marketing, and Business [...]
Growing In Vitro Diagnostics (IVD) Market To Set New Business Opportunities for Start Up Company Vidan Diagnostics Expected To Provide Access to Unique Tests Related to Monitoring of Diabetes and Sepis. SAN ANTONIO, TEXAS — April 7, 2018 — Today Vidan Diagnostics, LLC announces it has officially started business operations in the United States. Vidan [...]
